A Randomized. Double-Blind, Placebo-Controlled, Multicenter Phase III Study ComparingGW572016 And Letrozole Versus Letrozole In Subjects With Estrogen/Progesterone Receptor-Positive Advanced Or Metastatic Breast Cancer

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA Randomized. Double-Blind, Placebo-Controlled, Multicenter Phase III Study ComparingGW572016 And Letrozole Versus Letrozole In Subjects With Estrogen/Progesterone Receptor-Positive Advanced Or Metastatic Breast Cancer
StatusFinished
Effective start/end date1/04/04 → 31/12/11

Funding

  • GlaxoSmithKline